Dey, Inc.

PROFILE Dey helps people breathe easy. The company makes prescription drugs for the treatment of allergies and respiratory diseases. Its premeasured unit dose inhalation products include treatments for asthma and chronic obstructive pulmonary disease (COPD). Its Dey-Pak sodium chloride solution products are used in tracheal care and to dilute concentrated inhalation solutions. Dey also markets EpiPen autoinjectors, used by patients to self-administer epinephrine for allergic reactions, as well as certain diagnostic and delivery products. The company sells its products directly to physicians, institutional purchasers, wholesalers, pharmacies, and HMOs. Dey is an affiliate of Merck KgaA.  COMPETITION GlaxoSmithKline plc (GSK) Johnson & Johnson (JNJ) Schering-Plough Corporation (SGP)		FINANCIAL OVERVIEW Fiscal Year-End: December 1999 Sales (mil.): 300.00 1-Yr. Sales Growth: 12.7% Employees: 750 Revenue per employee: $400,000.00  KEY PEOPLE • Charles A. Rice     CEO • Pamela R. Marrs     CFO  CONTACT INFO 2751 Napa Valley Corporate Dr. Napa, CA 94558 US Phone: 707-224-3200 Fax: 707-224-9264 Online: Web Site

	Company Data   News, quotes & more

		Hoover's Company Capsule Copyright © 2001, Hoover's Inc. Austin, Texas. For changes and updates, contact Hoover's directly.